(DLB) Dolby Laboratories - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US25659T1079
DLB: Audio, Imaging, Codecs, Cinemas, Servers, Processors
Dolby Laboratories, Inc. is a global leader in audio and imaging technologies, revolutionizing the entertainment industry through its innovative solutions. Founded in 1965 and headquartered in San Francisco, Dolby is renowned for its cutting-edge audio codecs such as AAC and HE-AAC, and immersive technologies like Dolby Atmos and Dolby Vision. Their advancements have set industry standards, enhancing audio and visual experiences across cinema, broadcast, and live events. Beyond their technological prowess, Dolby has established partnerships and a strong market presence, solidifying their role in the global entertainment landscape.
Looking ahead, Dolbys stock is expected to navigate a consolidation phase over the next three months. Technically, the stock is trading above its SMA20 of 74.93 but below SMA50 and SMA200, indicating potential short-term weakness with long-term support. The Average True Range (ATR) of 2.26 suggests moderate volatility, with possible price fluctuations within a narrow range. Support levels may be tested near the SMA200 at 76.53, while resistance could be met around the SMA50 at 79.20.
From a fundamental perspective, Dolbys forward P/E of 18.38 signals market expectations for earnings growth, which may bolster the stock despite current SMA trends. However, the P/B ratio of 2.84 indicates a premium relative to book value, and the P/S ratio of 5.29 suggests a rich valuation compared to industry peers. A return on equity of 10.47% reflects moderate profitability. Overall, the stock is likely to experience sideways movement with potential upside driven by earnings growth and continued demand for immersive technologies.
Additional Sources for DLB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DLB Stock Overview
Market Cap in USD | 6,952m |
Sector | Industrials |
Industry | Specialty Business Services |
GiC Sub-Industry | Electronic Components |
IPO / Inception | 2005-02-17 |
DLB Stock Ratings
Growth Rating | 14.1 |
Fundamental | 48.2 |
Dividend Rating | 57.5 |
Rel. Strength | -9.35 |
Analysts | 4.67/5 |
Fair Price Momentum | 68.26 USD |
Fair Price DCF | 104.47 USD |
DLB Dividends
Dividend Yield 12m | 1.64% |
Yield on Cost 5y | 2.24% |
Annual Growth 5y | 6.93% |
Payout Consistency | 86.1% |
DLB Growth Ratios
Growth Correlation 3m | -75.7% |
Growth Correlation 12m | 18.2% |
Growth Correlation 5y | -2.2% |
CAGR 5y | 6.14% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | -0.95 |
Alpha | -13.37 |
Beta | 0.836 |
Volatility | 27.88% |
Current Volume | 392.8k |
Average Volume 20d | 387.9k |
As of April 26, 2025, the stock is trading at USD 75.75 with a total of 392,756 shares traded.
Over the past week, the price has changed by +7.19%, over one month by -7.06%, over three months by -6.21% and over the past year by -3.69%.
Partly, yes. Based on ValueRay Fundamental Analyses, Dolby Laboratories (NYSE:DLB) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.21 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DLB as of April 2025 is 68.26. This means that DLB is currently overvalued and has a potential downside of -9.89%.
Dolby Laboratories has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy DLB.
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DLB Dolby Laboratories will be worth about 76.9 in April 2026. The stock is currently trading at 75.75. This means that the stock has a potential upside of +1.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 100 | 32% |
Analysts Target Price | 100 | 32% |
ValueRay Target Price | 76.9 | 1.5% |